Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin

被引:396
作者
Leong, Kevin G.
Niessen, Kyle
Kulic, Iva
Raouf, Afshin
Eaves, Connie
Pollet, Ingrid
Karsan, Aly
机构
[1] British Columbia Canc Agcy, Dept Med Biophys, Vancouver, BC V5Z 1L3, Canada
[2] British Columbia Canc Agcy, Dept Pathol & Lab Med, Vancouver, BC V5Z 1L3, Canada
[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[4] Univ British Columbia, Expt Med Prog, Vancouver, BC V6T 2B5, Canada
[5] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada
[6] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada
关键词
D O I
10.1084/jem.20071082
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aberrant expression of Jagged1 and Notch1 are associated with poor outcome in breast cancer. However, the reason that Jagged1 and/or Notch overexpression portends a poor prognosis is unknown. We identify Slug, a transcriptional repressor, as a novel Notch target and show that elevated levels of Slug correlate with increased expression of Jagged1 in various human cancers. Slug was essential for Notch-mediated repression of E-cadherin, which resulted in beta-catenin activation and resistance to anoikis. Inhibition of ligand-induced Notch signaling in xenografted Slug-positive/E-cadherin-negative breast tumors promoted apoptosis and inhibited tumor growth and metastasis. This response was associated with down-regulated Slug expression, reexpression of E-cadherin, and suppression of active beta-catenin. Our findings suggest that ligand-induced Notch activation, through the induction of Slug, promotes tumor growth and metastasis characterized by epithelial-to-mesenchymal transition and inhibition of anoikis.
引用
收藏
页码:2935 / 2948
页数:14
相关论文
共 57 条
[41]   Soluble jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype [J].
Small, D ;
Kovalenko, D ;
Kacer, D ;
Liaw, L ;
Landriscina, M ;
Di Serio, C ;
Prudovsky, I ;
Maciag, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :32022-32030
[42]   Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue [J].
Stingl, J ;
Eaves, CJ ;
Zandieh, I ;
Emerman, JT .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (02) :93-109
[43]   Aberrant activation of Notch signaling in human breast cancer [J].
Stylianou, S ;
Clarke, RB ;
Brennan, K .
CANCER RESEARCH, 2006, 66 (03) :1517-1525
[44]   Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation [J].
Timmerman, LA ;
Grego-Bessa, J ;
Raya, A ;
Bertrán, E ;
Pérez-Pomares, JM ;
Díez, J ;
Aranda, S ;
Palomo, S ;
McCormick, F ;
Izpisúa-Belmonte, JC ;
de la Pompa, JL .
GENES & DEVELOPMENT, 2004, 18 (01) :99-115
[45]   Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells [J].
Tripathi, MK ;
Misra, S ;
Khedkar, SV ;
Hamilton, N ;
Irvin-Wilson, C ;
Sharan, C ;
Sealy, L ;
Chaudhuri, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) :17163-17171
[46]  
van de Wetering M, 2001, CANCER RES, V61, P278
[47]   Gene expression profiling predicts clinical outcome of breast cancer [J].
van't Veer, LJ ;
Dai, HY ;
van de Vijver, MJ ;
He, YDD ;
Hart, AAM ;
Mao, M ;
Peterse, HL ;
van der Kooy, K ;
Marton, MJ ;
Witteveen, AT ;
Schreiber, GJ ;
Kerkhoven, RM ;
Roberts, C ;
Linsley, PS ;
Bernards, R ;
Friend, SH .
NATURE, 2002, 415 (6871) :530-536
[48]   Host microenvironment in breast cancer development - Epithelial-mesenchymal transition in breast cancer development [J].
Vincent-Salomon, A ;
Thiery, JP .
BREAST CANCER RESEARCH, 2003, 5 (02) :101-106
[49]   Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells [J].
Weijzen, S ;
Rizzo, P ;
Braid, M ;
Vaishnav, R ;
Jonkheer, SM ;
Zlobin, A ;
Osborne, BA ;
Gottipati, S ;
Aster, JC ;
Hahn, WC ;
Rudolf, M ;
Siziopikou, K ;
Kast, WM ;
Miele, L .
NATURE MEDICINE, 2002, 8 (09) :979-986
[50]   Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia [J].
Weng, AP ;
Ferrando, AA ;
Lee, W ;
Morris, JP ;
Silverman, LB ;
Sanchez-Irizarry, C ;
Blacklow, SC ;
Look, AT ;
Aster, JC .
SCIENCE, 2004, 306 (5694) :269-271